Elanco Animal Health Incorporated - Laporan Laba Rugi (TTM)

Elanco Animal Health Incorporated
DE ˙ DB ˙ US28414H1032
€ 14.87 ↑0.09 (0.58%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Elanco Animal Health Incorporated menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 2,921 3,271 3,857 4,550 4,791 4,764 4,748 4,644 4,538 4,411 4,442 4,324 4,367 4,417 4,365 4,492 4,454 4,439 4,427 4,484
Change (%) 11.98 17.92 17.97 5.30 -0.56 -0.34 -2.19 -2.28 -2.80 0.70 -2.66 0.99 1.14 -1.18 2.91 -0.85 -0.34 -0.27 1.29
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 1,448 1,577 1,813 2,068 2,161 2,068 2,008 1,941 1,911 1,913 1,898 1,848 1,863 1,931 1,952 2,013 2,016 2,003 1,997 2,030
Change (%) 8.90 14.97 14.07 4.50 -4.30 -2.90 -3.34 -1.55 0.10 -0.78 -2.63 0.81 3.65 1.09 3.12 0.15 -0.64 -0.30 1.65
% of Revenue 49.58 48.21 47.01 45.45 45.11 43.41 42.29 41.80 42.11 43.37 42.73 42.74 42.66 43.72 44.72 44.81 45.26 45.12 45.11 45.27
Gross Operating Profit 1,473 1,694 2,044 2,482 2,630 2,696 2,740 2,703 2,627 2,498 2,544 2,476 2,504 2,486 2,413 2,479 2,438 2,436 2,430 2,454
Change (%) 15.01 20.66 21.43 5.96 2.51 1.63 -1.35 -2.81 -4.91 1.84 -2.67 1.13 -0.72 -2.94 2.74 -1.65 -0.08 -0.25 0.99
% of Revenue 50.42 51.79 52.99 54.55 54.89 56.59 57.71 58.20 57.89 56.63 57.27 57.26 57.34 56.28 55.28 55.19 54.74 54.88 54.89 54.73
SG&A 810 988 1,153 1,373 1,431 1,395 1,372 1,334 1,290 1,259 1,263 1,273 1,289 1,280 1,290 1,291 1,301 1,308 1,312 1,358
Change (%) 21.99 16.70 19.08 4.22 -2.52 -1.65 -2.77 -3.30 -2.40 0.32 0.79 1.26 -0.70 0.78 0.08 0.77 0.54 0.31 3.51
% of Revenue 27.73 30.20 29.89 30.18 29.87 29.28 28.90 28.73 28.43 28.54 28.43 29.44 29.52 28.98 29.55 28.74 29.21 29.47 29.64 30.29
R&D 281 329 349 384 390 369 361 349 333 321 321 320 328 327 333 341 342 344 351 354
Change (%) 16.96 6.08 10.03 1.56 -5.38 -2.17 -3.32 -4.58 -3.60 0.00 -0.31 2.50 -0.30 1.83 2.40 0.29 0.58 2.03 0.85
% of Revenue 9.63 10.06 9.05 8.44 8.14 7.75 7.60 7.52 7.34 7.28 7.23 7.40 7.51 7.40 7.63 7.59 7.68 7.75 7.93 7.89
OpEx 2,788 3,254 3,770 4,360 4,562 4,388 4,287 4,174 4,071 4,021 4,007 3,969 4,020 4,086 4,122 4,187 4,194 4,182 4,182 4,269
Change (%) 16.73 15.86 15.65 4.63 -3.81 -2.30 -2.64 -2.47 -1.23 -0.35 -0.95 1.28 1.64 0.88 1.58 0.17 -0.29 0.00 2.08
% of Revenue 95.44 99.48 97.74 95.82 95.22 92.11 90.29 89.88 89.71 91.16 90.21 91.79 92.05 92.51 94.43 93.21 94.16 94.21 94.47 95.21
Operating Income 133 17 87 190 229 376 461 470 467 390 435 355 347 331 243 305 260 257 245 215
Change (%) -87.25 411.76 118.39 20.53 64.19 22.61 1.95 -0.64 -16.49 11.54 -18.39 -2.25 -4.61 -26.59 25.51 -14.75 -1.15 -4.67 -12.24
% of Revenue 4.56 0.52 2.26 4.18 4.78 7.89 9.71 10.12 10.29 8.84 9.79 8.21 7.95 7.49 5.57 6.79 5.84 5.79 5.53 4.79
Interest Expense -108 -150 -195 -230 -242 -236 -227 -234 -234 -241 -253 -260 -272 -277 -279 -270 -256 -235 -209 -192
Change (%) 39.28 30.00 17.95 5.22 -2.48 -3.81 3.08 -0.00 2.99 4.98 2.77 4.62 1.84 0.72 -3.23 -5.19 -8.20 -11.06 -8.13
% of Revenue -3.69 -4.59 -5.06 -5.05 -5.05 -4.95 -4.78 -5.04 -5.16 -5.46 -5.70 -6.01 -6.23 -6.27 -6.39 -6.01 -5.75 -5.29 -4.72 -4.28
Net Income -246 -574 -572 -729 -698 -483 -371 -171 -132 -78 -26 -113 -1,144 -1,231 -1,302 -1,255 205 338 373 434
Change (%) 132.86 -0.35 27.45 -4.25 -30.80 -23.19 -53.91 -22.81 -40.91 -66.67 334.62 912.39 7.60 5.77 -3.61 -116.33 64.88 10.36 16.35
% of Revenue -8.44 -17.55 -14.83 -16.02 -14.57 -10.14 -7.81 -3.68 -2.91 -1.77 -0.59 -2.61 -26.20 -27.87 -29.83 -27.94 4.60 7.61 8.43 9.68

Source: Capital IQ

Other Listings
MX:ELAN
US:ELAN US$ 18.43
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista